Elmore, Charles S.
AstraZeneca (Sweden)
3 papers on CoChatORCID 0000-0001-7434-8307
Most cited papers
- Verified
Apolipoprotein E binding drives structural and compositional rearrangement of mRNA-containing lipid nanoparticles
Sebastiani, F., Yanez Arteta, M., Lerche, M., Porcar, L., Lang, C., Bragg, R. A., Elmore, C. S., Krishnamurthy, V. R., Russell, R. A., Darwish, T., et al. (2021) · ACS Nano
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 409
- Verified
Studies on the Metabolism of Troglitazone to Reactive Intermediates in Vitro and in Vivo. Evidence for Novel Biotransformation Pathways Involving Quinone Methide Formation and Thiazolidinedione Ring Scission
Kassahun, K., Pearson, P. G., Tang, W., McIntosh, I., Leung, K., Elmore, C., Dean, D., Wang, R., Doss, G., & Baillie, T. A. (2001) · Chemical Research in Toxicology
Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism
Cited by 311
- Verified
Multiple Compound-Related Adverse Properties Contribute to Liver Injury Caused by Endothelin Receptor Antagonists
Kenna, J. G., Stahl, S. H., Eakins, J. A., Foster, A. J., Andersson, L. C., Bergare, J., Billger, M., Elebring, M., Elmore, C. S., & Thompson, R. A. (2015) · The Journal of Pharmacology and Experimental Therapeutics
Drug-Induced Hepatotoxicity and ProtectionPharmacogenetics and Drug Metabolism
Cited by 48
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free